Cognizant Technology Solutions Corporation

CTSH Technology Information Technology Services NASDAQ

$80.72

+$0.52 (+0.65%)

Open: $79.97 | High: $81.15 | Low: $79.48 | Prev Close: $80.20

Market Cap: $39.67B

Volume: 3.1M | Avg: 4.6M

Last updated: December 05, 2025 at 10:01 PM
Investment Rating
A

Buy

Overall Score: 80/100


Rating Breakdown:
DCF Score 4/5
80%
Buy
ROE Score 4/5
80%
Buy
ROA Score 5/5
100%
Strong Buy
D/E Score 3/5
60%
Neutral
P/E Score 3/5
60%
Neutral
P/B Score 4/5
80%
Buy

Stock Score Analysis
D

Stock Score: 535

Comprehensive Quality Assessment


Component Breakdown:
Efficiency 40
Financial Health 100
Growth 0
Market Sentiment 20
Risk 50
Lower is better
Valuation 25
Momentum 0

Valuation Metrics
Valuation Ratios
P/E Ratio 18.69
P/B Ratio 2.63
P/S Ratio 1.90
EPS $4.32
Beta 0.97
Shares Outstanding 491.50M

Price Range & Moving Averages
52-Week High $90.82
52-Week Low $65.15
SMA 50 $70.97
SMA 200 $74.66

Dividend Information
Dividend Yield 1.54%
Annual Dividend $1.24

Earnings
Next Earnings January 29, 2026 12:00 PM ET
Financial Ratios
Margins
Gross Margin 34.1%
Operating Margin 15.8%
Net Margin 10.2%

Returns
ROE 14.3%
ROA 10.6%

Liquidity & Leverage
Debt/Equity 0.08
Current Ratio 2.36
Quick Ratio 2.36
Balance Sheet
Total Assets $19.97B
Total Liabilities $5.56B
Total Equity $14.41B

Cash $2.23B
Total Debt $1.50B
Net Debt $-728,000,000
Income Statement
Revenue $19.74B
Gross Profit $6.78B
Operating Income $2.89B
Net Income $2.24B

EBITDA $3.53B
Revenue/Share $42.92
Cash Flow
Operating CF $2.12B
CapEx $297.00M
Free Cash Flow $1.83B

Book Value/Share $30.65
Tangible Book/Share $13.01
Equity/Share $30.65
Technical Indicators
RSI (14) 73.55 Overbought
MACD
2.20 Signal: 1.74
Volatility 27.43%
Trading Signal Overbought
Performance & Returns
Total Returns
1 Year -8.72%

Risk-Adjusted Returns
Sharpe Ratio -0.42 Poor
Volatility (Ann.) 27.8% Moderate

vs S&P 500 (SPY)
CTSH (1Y) -8.72%
S&P 500 (1Y) +11.86%
Alpha (Excess Return) -20.58%
Sector Comparison (Technology)
Compared to 83 peers in Technology
Metric CTSH Sector Avg Percentile
P/E Ratio 18.69 50.28 14%
P/B Ratio 2.63 2.66 17%
ROE (%) 14.31% 49.31% 37%
Net Margin (%) 10.20% 17.74% 24%
Stock Score 535 518.0 56%
1Y Return (%) -8.72% +15.04% 28%
Percentile: 0% = worst in sector, 100% = best in sector
Historical Price Analysis (Last 200 Days)
Technical Analysis
Ticker Close SMA 5 SMA 8 SMA 13 SMA 50 SMA 200 RSI (14) MACD Volatility (%) Volume Signal SMA Decision
CTSH $80.72 $78.45 $77.59 $75.71 $70.97 $74.66 73.55 2.20 27.43% 4481607 Strong Long Bullish Stack
Candlestick Patterns

There wasn't any recognizable pattern for the CTSH stock

News Sentiment
📊 Ticker 📰 Headline 💭 Sentiment 📡 Source 🔗 URL
CTSH Cognizant double son engagement en faveur de Synapse en se fixant pour nouvel objectif d'atteindre deux millions de personnes d'ici à 2030 Neutral prnewswire.com Read More
CTSH Cognizant verdoppelt sein Engagement für Synapse mit einem neuen Ziel von zwei Millionen bis 2030 Neutral prnewswire.com Read More
CTSH Cognizant Doubles Down on Synapse Commitment with New Target to Reach Two Million by 2030 Neutral prnewswire.com Read More
CTSH Cognizant and Merchants Fleet Set New Standard for Fleet Management Efficiency Neutral prnewswire.com Read More
CTSH 5 Undervalued Stocks With Low Price-to-Sales Ratios & Strong Momentum Neutral zacks.com Read More
Company Information

Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. The company offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; the shift towards consumerism, outcome-based contracting, digital health, delivering integrated seamless, omni-channel, and patient-centered experience; and services that drive operational improvements in areas, such as clinical development, pharmacovigilance, and manufacturing, as well as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. It also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and digital content, the creation of personalized user experience, and acceleration of digital engineering services to information, media and entertainment, and communications and technology companies. The company was founded in 1994 and is headquartered in Teaneck, New Jersey.


CEO Ravi Kumar Singisetti
Employees 336300
Country US
IPO Date 1998-06-19
Exchange NASDAQ
Website https://www.cognizant.com
Sector Technology
Industry Information Technology Services
Similar Stocks (Technology - Information Technology Services)
IBM

International Business Machines Corporation

Price: $307.94
Change: -0.02%
Market Cap: $2878B
P/E: 36.75
Score: E (465)
View Details
ACN

Accenture plc

Price: $266.59
Change: -1.02%
Market Cap: $1665B
P/E: 21.94
Score: D (525)
View Details
FISV

Fiserv, Inc.

Price: $66.28
Change: +0.33%
Market Cap: $3602B
P/E: 10.24
Score: D (565)
View Details
FIS

Fidelity National Information Services, Inc.

Price: $66.66
Change: +1.69%
Market Cap: $3451B
P/E: 208.31
Score: E (425)
View Details
Rating Metrics Explained
DCF Score (Discounted Cash Flow)

Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.

ROE Score (Return on Equity)

Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.

ROA Score (Return on Assets)

Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.

D/E Score (Debt-to-Equity)

Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.

P/E Score (Price-to-Earnings)

Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.

P/B Score (Price-to-Book)

Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.


Rating Recommendations:

Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:

  • Strong Buy (5/5): Excellent score - strong positive indicator
    • The metric significantly outperforms industry averages (top 20% of companies)
    • Indicates exceptional financial health or attractive valuation in that category
  • Buy (4/5): Good score - positive indicator
    • Above-average performance (top 40% of companies)
    • Shows strong fundamentals with room for improvement
  • Neutral (3/5): Average score - neutral indicator
    • Performance in line with industry median (middle 20%)
    • Neither significantly positive nor negative signal
  • Sell (2/5): Below average - negative indicator
    • Below-average performance (bottom 40% of companies)
    • Suggests weakness in this particular metric
  • Strong Sell (1/5): Poor score - strong negative indicator
    • Significantly underperforms industry (bottom 20%)
    • Indicates potential risk or overvaluation in that category
Note: The overall rating combines all six component scores to provide a comprehensive investment assessment. No single metric should be used in isolation for investment decisions.